» Articles » PMID: 24465457

Plasma Selenium Biomarkers in Low Income Black and White Americans from the Southeastern United States

Overview
Journal PLoS One
Date 2014 Jan 28
PMID 24465457
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Biomarkers of selenium are necessary for assessing selenium status in humans, since soil variation hinders estimation of selenium intake from foods. In this study, we measured the concentration of plasma selenium, selenoprotein P (SEPP1), and glutathione peroxidase (GPX3) activity and their interindividual differences in 383 low-income blacks and whites selected from a stratified random sample of adults aged 40-79 years, who were participating in a long-term cohort study in the southeastern United States (US). We assessed the utility of these biomarkers to determine differences in selenium status and their association with demographic, socio-economic, dietary, and other indicators. Dietary selenium intake was assessed using a validated food frequency questionnaire designed for the cohort, matched with region-specific food selenium content, and compared with the US Recommended Dietary Allowances (RDA) set at 55 µg/day. We found that SEPP1, a sensitive biomarker of selenium nutritional status, was significantly lower among blacks than whites (mean 4.4 ± 1.1 vs. 4.7 ± 1.0 mg/L, p = 0.006), with blacks less than half as likely to have highest vs. lowest quartile SEPP1 concentration (Odds Ratio (OR) 0.4, 95% Confidence Interval (CI) 0.2-0.8). The trend in a similar direction was observed for plasma selenium among blacks and whites, (mean 115 ± 15.1 vs. 118 ± 17.7 µg/L, p = 0.08), while GPX3 activity did not differ between blacks and whites (136 ± 33.3 vs. 132 ± 33.5 U/L, p = 0.320). Levels of the three biomarkers were not correlated with estimated dietary selenium intake, except for SEPP1 among 10% of participants with the lowest selenium intake (≤ 57 µg/day). The findings suggest that SEPP1 may be an effective biomarker of selenium status and disease risk in adults and that low selenium status may disproportionately affect black and white cohort participants.

Citing Articles

Selenium status and its determinants in very old adults: insights from the Newcastle 85+ Study.

Perri G, Mathers J, Martin-Ruiz C, Parker C, Walsh J, Eastell R Br J Nutr. 2023; 131(5):901-910.

PMID: 37877251 PMC: 10864996. DOI: 10.1017/S0007114523002398.


Selenium and Redox Enzyme Activity in Pregnant Women Exposed to Methylmercury.

Branco V, Carvalho L, Barboza C, Mendes E, Cavaco A, Carvalho C Antioxidants (Basel). 2022; 11(11).

PMID: 36421477 PMC: 9687717. DOI: 10.3390/antiox11112291.


Oral Cholecalciferol Supplementation in Sahara Black People with Chronic Kidney Disease Modulates Cytokine Storm, Oxidative Stress Damage and Athero-Thromboembolic Risk.

Zoubiri H, Tahar A, AitAbderrhmane S, Saidani M, Koceir E Nutrients. 2022; 14(11).

PMID: 35684085 PMC: 9182799. DOI: 10.3390/nu14112285.


The Interaction between Dietary Selenium Intake and Genetics in Determining Cancer Risk and Outcome.

Kadkol S, Diamond A Nutrients. 2020; 12(8).

PMID: 32806741 PMC: 7468715. DOI: 10.3390/nu12082424.


Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death.

Schomburg L, Orho-Melander M, Struck J, Bergmann A, Melander O Nutrients. 2019; 11(8).

PMID: 31404994 PMC: 6723215. DOI: 10.3390/nu11081852.


References
1.
Xia Y, Hill K, Li P, Xu J, Zhou D, Motley A . Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr. 2010; 92(3):525-31. PMC: 2921536. DOI: 10.3945/ajcn.2010.29642. View

2.
Hurst R, Armah C, Dainty J, Hart D, Teucher B, Goldson A . Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010; 91(4):923-31. PMC: 2844680. DOI: 10.3945/ajcn.2009.28169. View

3.
Duffield-Lillico A, Reid M, Turnbull B, Combs Jr G, Slate E, Fischbach L . Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002; 11(7):630-9. View

4.
Klapcinska B, Poprzecki S, Danch A, Sobczak A, Kempa K . Selenium levels in blood of upper Silesian population: evidence of suboptimal selenium status in a significant percentage of the population. Biol Trace Elem Res. 2005; 108(1-3):1-15. DOI: 10.1385/BTER:108:1-3:001. View

5.
Combs Jr G, Watts J, Jackson M, Johnson L, Zeng H, Scheett A . Determinants of selenium status in healthy adults. Nutr J. 2011; 10:75. PMC: 3160353. DOI: 10.1186/1475-2891-10-75. View